392 related articles for article (PubMed ID: 24067872)
1. Purinergic signalling: pathophysiology and therapeutic potential.
Burnstock G
Keio J Med; 2013; 62(3):63-73. PubMed ID: 24067872
[TBL] [Abstract][Full Text] [Related]
2. Purinergic signalling: past, present and future.
Burnstock G
Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040
[TBL] [Abstract][Full Text] [Related]
3. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future.
Burnstock G
Bioessays; 2012 Mar; 34(3):218-25. PubMed ID: 22237698
[TBL] [Abstract][Full Text] [Related]
4. Introduction to Purinergic Signaling.
Burnstock G
Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
[TBL] [Abstract][Full Text] [Related]
5. Introduction to Purinergic Signalling in the Brain.
Burnstock G
Adv Exp Med Biol; 2020; 1202():1-12. PubMed ID: 32034706
[TBL] [Abstract][Full Text] [Related]
6. Introductory overview of purinergic signalling.
Burnstock G
Front Biosci (Elite Ed); 2011 Jun; 3(3):896-900. PubMed ID: 21622101
[TBL] [Abstract][Full Text] [Related]
7. Purinergic signalling--an overview.
Burnstock G
Novartis Found Symp; 2006; 276():26-48; discussion 48-57, 275-81. PubMed ID: 16805422
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term (trophic) purinergic signalling.
Burnstock G
Philos Trans R Soc Lond B Biol Sci; 2016 Aug; 371(1700):. PubMed ID: 27377731
[TBL] [Abstract][Full Text] [Related]
9. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved.
De Man JG; De Winter BY; Seerden TC; De Schepper HU; Herman AG; Pelckmans PA
Br J Pharmacol; 2003 Nov; 140(6):1108-16. PubMed ID: 14530212
[TBL] [Abstract][Full Text] [Related]
10. Physiology and pathophysiology of purinergic neurotransmission.
Burnstock G
Physiol Rev; 2007 Apr; 87(2):659-797. PubMed ID: 17429044
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of astroglial purinergic signalling.
Franke H; Verkhratsky A; Burnstock G; Illes P
Purinergic Signal; 2012 Sep; 8(3):629-57. PubMed ID: 22544529
[TBL] [Abstract][Full Text] [Related]
12. Purinergic signalling: from normal behaviour to pathological brain function.
Burnstock G; Krügel U; Abbracchio MP; Illes P
Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
[TBL] [Abstract][Full Text] [Related]
13. Biology of purinergic signalling: its ancient evolutionary roots, its omnipresence and its multiple functional significance.
Verkhratsky A; Burnstock G
Bioessays; 2014 Jul; 36(7):697-705. PubMed ID: 24782352
[TBL] [Abstract][Full Text] [Related]
14. Purinergic signalling in the gastrointestinal tract and related organs in health and disease.
Burnstock G
Purinergic Signal; 2014 Mar; 10(1):3-50. PubMed ID: 24307520
[TBL] [Abstract][Full Text] [Related]
15. Historical review: ATP as a neurotransmitter.
Burnstock G
Trends Pharmacol Sci; 2006 Mar; 27(3):166-76. PubMed ID: 16487603
[TBL] [Abstract][Full Text] [Related]
16. Overview. Purinergic mechanisms.
Burnstock G
Ann N Y Acad Sci; 1990; 603():1-17; discussion 18. PubMed ID: 1981306
[TBL] [Abstract][Full Text] [Related]
17. The journey to establish purinergic signalling in the gut.
Burnstock G
Neurogastroenterol Motil; 2008 May; 20 Suppl 1():8-19. PubMed ID: 18402638
[TBL] [Abstract][Full Text] [Related]
18. Purinergic regulation of sound transduction and auditory neurotransmission.
Housley GD; Jagger DJ; Greenwood D; Raybould NP; Salih SG; Järlebark LE; Vlajkovic SM; Kanjhan R; Nikolic P; Muñoz DJ; Thorne PR
Audiol Neurootol; 2002; 7(1):55-61. PubMed ID: 11914528
[TBL] [Abstract][Full Text] [Related]
19. Introduction to purinergic signalling in the brain.
Burnstock G
Adv Exp Med Biol; 2013; 986():1-12. PubMed ID: 22879061
[TBL] [Abstract][Full Text] [Related]
20. Potential therapeutic targets in the rapidly expanding field of purinergic signalling.
Burnstock G
Clin Med (Lond); 2002; 2(1):45-53. PubMed ID: 11871639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
